Quantcast
The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:Fido Creates Biotech Group Not Rated 0.0 Email Routing List Email & Route  Print Print
Friday, March 22, 2002

PORTFOLIO PROS
Fido Creates Biotech Group

by: InvestmentWires Staff, 

Fidelity is taking the collapse of the venture capital market as an opportunity to make lemonade from lemons. The effort features a distinctly Twenty First Century twist with a focus on biotech rather than silicon tech. To spearhead the effort the Boston Behemoth hired David A. Lowe as its new chief scientific officer and executive vice president for its Biosciences Group. Lowe is a former neurobiologist with the US unit of Swiss drug giant Roche Group. Mark Peterson is president of the group and Jason Rhodes a principal. Fidelity has yet to make any investments through the group.  

See the list of all the 2002 Most Influential People



Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE

0.0
 Do You Recommend This Story?



GO TO: MFWire
Return to Top
 News Archives
2024: Q2Q1
2023: Q4Q3Q2Q1
2022: Q4Q3Q2Q1
2021: Q4Q3Q2Q1
2020: Q4Q3Q2Q1
2019: Q4Q3Q2Q1
2018: Q4Q3Q2Q1
2017: Q4Q3Q2Q1
2016: Q4Q3Q2Q1
2015: Q4Q3Q2Q1
2014: Q4Q3Q2Q1
2013: Q4Q3Q2Q1
2012: Q4Q3Q2Q1
2011: Q4Q3Q2Q1
2010: Q4Q3Q2Q1
2009: Q4Q3Q2Q1
2008: Q4Q3Q2Q1
2007: Q4Q3Q2Q1
2006: Q4Q3Q2Q1
2005: Q4Q3Q2Q1
2004: Q4Q3Q2Q1
2003: Q4Q3Q2Q1
2002: Q4Q3Q2Q1
 Subscribe via RSS:
Raw XML
Add to My Yahoo!
follow us in feedly




©All rights reserved to InvestmentWires, Inc. 1997-2024
14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
Privacy Policy :: Terms of Use